Nordic Nanovector ASA: Invitation to First Quarter 2019 Results Presentation and Webcast

Thursday, May 16, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

OSLO, Norway, May 16, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will report its first quarter 2019 results on Thursday, 23 May 2019.

A presentation by Nordic Nanovector's senior management team will take place at 8:30am CEST at:

Thon Hotel Vika Atrium, Munkedamsveien

45, 0250 Oslo

Meeting Room: NYLAND 

The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media

The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim Reports/2019 from 7:00am CEST the same day.

For further information, please contact: 

IR enquiries Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44-7561-431-762Email: ir@nordicnanovector.com 

Media Enquiries Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44-207-638-9571 Email: nordicnanovector@citigatedewerogerson.com  

About Nordic Nanovector: 

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.

Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting radioimmunotherapy designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need,

representing a growing market forecast to be worth nearly USD 29 billion by 2026. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. Further information can be found at www.nordicnanovector.com.

This information is subject to a duty of disclosure pursuant to Sections 4-2 and 5-12 of the Securities Trading Act. 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/nordic-nanovector/r/nordic-nanovector-asa--invitation-to-first-quarter-2019-results-presentation-and-webcast,c2815121

Cision View original content:http://www.prnewswire.com/news-releases/nordic-nanovector-asa-invitation-to-first-quarter-2019-results-presentation-and-webcast-300851446.html

SOURCE Nordic Nanovector



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store